Healthcare - Sector
CLLS is currently covered by 3 analysts with an average price target of $8.5. This is a potential upside of $7.58 (823.91%) from yesterday's end of day stock price of $0.92.
Cellectis SA's activity chart (see below) currently has 57 price targets and 59 ratings on display. The stock rating distribution of CLLS is 100% BUY.
Analysts' price targets on this stock were met 34.58% of the time, taking 86.88 days on average.
Highest price target for CLLS is $9, Lowest price target is $8, average price target is $8.5.
Most recent stock forecast was given by JACK ALLEN from BAIRD on 15-Sep-2026. First documented stock forecast 20-Apr-2015.
Currently out of the existing stock ratings of CLLS, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2026
$8
$6.82 (577.97%)
$10
2 months 6 days ago
(15-Sep-2026)
1/3 (33.33%)
$6.39 (396.89%)
6
Buy Since 30-Nov-2021
$8
2 months 6 days ago
(15-Sep-2026)
0/7 (0%)
$3.84 (92.31%)
Buy Since 13-May-2022
$9
$6.17 (218.02%)
$8
5 months 24 days ago
(28-May-2026)
2/5 (40%)
$5.37 (147.93%)
266
Buy Since 11-May-2020
$10
$21
2 years 16 days ago
(05-Nov-2024)
4/5 (80%)
$8.22 (461.80%)
83
Buy Since 28-Dec-2017
$10
2 years 5 months 9 days ago
(12-Jun-2024)
0/5 (0%)
$7.58 (313.22%)
What is CLLS (Cellectis SA) average time for price targets to be met?
Which analyst most recently updated their price target on CLLS (Cellectis SA)?
Which analyst has the most public recommendations on CLLS (Cellectis SA)?
Which analyst is the currently most bullish on CLLS (Cellectis SA)?
Which analyst is the currently most reserved on CLLS (Cellectis SA)?